Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Aortic Interventions: Features

Gore Video
Video
How Are Unmet Needs in EVAR Being Addressed?
11/24/2021
Dr. Erin Moore shares his thoughts on what those needs are and how a relatively new EVAR device was designed to meet them.
Dr. Erin Moore shares his thoughts on what those needs are and how a relatively new EVAR device was designed to meet them.
Dr. Erin Moore shares his...
11/24/2021
Vascular Disease Management
Dr. Matthew Eagleton
Video
What Is the Value of Internal Iliac Artery Preservation?
10/27/2021
Approximately 25% of all AAA cases extend to the common iliac arteries. What is the value of internal iliac artery preservation?
Approximately 25% of all AAA cases extend to the common iliac arteries. What is the value of internal iliac artery preservation?
Approximately 25% of all AAA...
10/27/2021
Vascular Disease Management
Case Report
Anteroseptal Myocardial Infarction and Claudication as Manifestations of an Acute Extensive Aortic Dissection: A Case Report
04/19/2021
A 50-year-old man with a medical history of active smoking and diagnosed with type 2 diabetes mellitus was admitted to the ED complaining of sudden acute chest and left groin pain lasting 1 hour.
A 50-year-old man with a medical history of active smoking and diagnosed with type 2 diabetes mellitus was admitted to the ED complaining of sudden acute chest and left groin pain lasting 1 hour.
A 50-year-old man with a medical...
04/19/2021
Vascular Disease Management
Case Report
COVID-19 and Aortic Thrombus: An Unusual and Dangerous Combination
02/16/2021
The authors present a case of COVID-19 associated with aortic thrombus in a 62-year-old female patient with comorbidities.
The authors present a case of COVID-19 associated with aortic thrombus in a 62-year-old female patient with comorbidities.
The authors present a case of...
02/16/2021
Vascular Disease Management
Original Research
Predictors of Major Adverse Anatomical Events After Elective Endovascular Abdominal Aortic Aneurysm Repair at a Tertiary Referral Center
10/22/2020
The objective of this study is to identify the predictors for adverse anatomical outcomes following EVAR, and their impact on re-intervention rates and clinical outcomes.
The objective of this study is to identify the predictors for adverse anatomical outcomes following EVAR, and their impact on re-intervention rates and clinical outcomes.
The objective of this study is...
10/22/2020
Vascular Disease Management
What Is the Appropriate Pre-procedural Evaluation of Patients With Vascular Disorder?
Video
What Is the Appropriate Pre-procedural Evaluation of Patients With Vascular Disorder?
08/24/2020
In this month's video, watch Dr. Walker provide his insight and commentary on the original research from Sultan et al: "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
In this month's video, watch Dr. Walker provide his insight and commentary on the original research from Sultan et al: "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
In this month's video, watch Dr....
08/24/2020
Vascular Disease Management
Original Research
Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair
08/19/2020
This study aims to assess the predictive utility of pre-operative NT-proBNP levels on the cardiovascular outcomes of abdominal aortic aneurysm repair.
This study aims to assess the predictive utility of pre-operative NT-proBNP levels on the cardiovascular outcomes of abdominal aortic aneurysm repair.
This study aims to assess the...
08/19/2020
Vascular Disease Management
What Is the Appropriate Pre-procedural Evaluation of Patients With Vascular Disorders?
Editor's Corner
What Is the Appropriate Pre-procedural Evaluation of Patients With Vascular Disorders?
08/19/2020
Dr. Walker provides insight and commentary on "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
Dr. Walker provides insight and commentary on "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
Dr. Walker provides insight and...
08/19/2020
Vascular Disease Management
Case Report
Ruptured Abdominal Aortic Aneurysm With Incidental Large Splenic Artery Aneurysm: An Unusual Case Report
06/23/2020
Ruptured abdominal aortic aneurysms (rAAA) represent the 13th leading cause of mortality in the United States.
Ruptured abdominal aortic aneurysms (rAAA) represent the 13th leading cause of mortality in the United States.
Ruptured abdominal aortic...
06/23/2020
Vascular Disease Management
Evaluating Long-Term Outcomes
Videos
Evaluating Long-Term Outcomes in 180 Patients Treated With the Endurant Stent Graft System
04/28/2020
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
04/28/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement